Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer

The use of chemotherapy has significantly increased in patients with resected stage IB to IIIA NSCLC. Although clinicians have increasingly adopted evidence-based recommendations, significant treatment gaps persist and represent areas for quality improvement.